Results
13
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
13 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
UNH | €499.30 | 2.1% | 1.9% | €472.1b | €618.87 | PE33x | E21.5% | 1.6% | ||
ABT | €110.54 | 0.1% | 9.4% | €197.4b | €126.77 | PE34.4x | E11.6% | 2.1% | ||
SYK | €350.50 | 0.4% | 29.9% | €137.8b | €394.76 | PE38.4x | E11.6% | 0.9% | ||
ABC | €219.10 | 0.9% | 13.6% | €44.3b | €254.61 | PE29.4x | E14.8% | 1.0% | ||
IDXX | €400.70 | 0.9% | -18.6% | €34.0b | €461.54 | PE39.3x | E10.3% | n/a | ||
RMD | €223.50 | 0% | 46.5% | €34.0b | €247.29 | PE30.6x | E11.1% | 0.9% | ||
DXCM | €77.98 | 1.5% | -30.6% | €31.7b | €92.59 | PE46.5x | E16.1% | n/a | ||
PHIA | €24.34 | -0.7% | 18.3% | €22.8b | €28.74 | PS1.3x | E62.8% | n/a | ||
FRE | €33.50 | 0.09% | 15.5% | €18.9b | €40.87 | PS0.8x | E37.0% | n/a | ||
HSIC | €66.54 | -1.4% | -1.7% | €8.6b | €72.07 | PE27.4x | E26.7% | n/a | ||
DEMA | €35.14 | -1.5% | -10.5% | €57.2b | €39.72 | PE22.6x | E12.3% | n/a | ||
XRAY | €17.88 | -2.2% | -45.0% | €3.7b | €22.05 | PS0.9x | E73.9% | 3.4% | ||
COP2 | €21.90 | 0.6% | -38.3% | €1.1b | €21.56 | PE45x | E30.5% | 4.6% |